Found: 53
Select item for more details and to access through your institution.
Principles for designing future regimens for multidrug-resistant tuberculosis.
- Published in:
- Bulletin of the World Health Organization, 2014, v. 92, n. 1, p. 68, doi. 10.2471/BLT.13.122028
- By:
- Publication type:
- Article
A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 3, p. 501, doi. 10.1002/sim.9961
- By:
- Publication type:
- Article
The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 10, p. 1376, doi. 10.1164/rccm.202206-1118OC
- By:
- Publication type:
- Article
To Err Is Human, to Forgive Is Pharmacodynamic.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 2, p. 127, doi. 10.1164/rccm.202208-1629ED
- By:
- Publication type:
- Article
Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2021, v. 204, n. 9, p. 1086, doi. 10.1164/rccm.202101-0117OC
- By:
- Publication type:
- Article
Reply to Swindells : Trials of Tuberculosis-Preventive Therapy in People with HIV Infection.
- Published in:
- 2020
- By:
- Publication type:
- letter
Reply to Swindells et al.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).
- Published in:
- 2016
- By:
- Publication type:
- journal article
World TB Day 2016: an interview with leading experts in tuberculosis research.
- Published in:
- 2016
- By:
- Publication type:
- editorial
Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited Settings.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2415576, doi. 10.1001/jamanetworkopen.2024.15576
- By:
- Publication type:
- Article
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
- Published in:
- Pilot & Feasibility Studies, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40814-023-01281-7
- By:
- Publication type:
- Article
Reply to Dodd and Proschan.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. suppl_2, p. S250, doi. 10.1093/infdis/jis041
- By:
- Publication type:
- Article
Innovative trial designs are practical solutions for improving the treatment of tuberculosis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Biomarkers and Surrogate End Points in Clinical Trials of Tuberculosis Treatment.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 5, p. 1558, doi. 10.1093/jac/dku553
- By:
- Publication type:
- Article
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e580, doi. 10.1093/cid/ciac707
- By:
- Publication type:
- Article
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 4, p. 560, doi. 10.1093/cid/ciab1037
- By:
- Publication type:
- Article
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
- Published in:
- Trials, 2014, v. 15, n. 1, p. 353, doi. 10.1186/1745-6215-15-353
- By:
- Publication type:
- Article
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- 2015
- By:
- Publication type:
- letter
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 4, p. 525, doi. 10.1164/rccm.201506-1061le
- By:
- Publication type:
- Article
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. 1058, doi. 10.1164/rccm.201407-1264OC
- By:
- Publication type:
- Article
A dose escalating trial to optimize the dose of rifampin in the treatment of tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. E1, doi. 10.1164/rccm.201407-1264oc
- By:
- Publication type:
- Article
Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 8, p. 972, doi. 10.1164/rccm.201105-0827WS
- By:
- Publication type:
- Article
A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis.
- Published in:
- BMC Medical Research Methodology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2288-13-139
- By:
- Publication type:
- Article
A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Rethinking non-inferiority: a practical trial design for optimising treatment duration.
- Published in:
- Clinical Trials, 2018, v. 15, n. 5, p. 477, doi. 10.1177/1740774518778027
- By:
- Publication type:
- Article
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.
- Published in:
- Clinical Trials, 2017, v. 14, n. 5, p. 451, doi. 10.1177/1740774517725697
- By:
- Publication type:
- Article
An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063840
- By:
- Publication type:
- Article
Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-07999-w
- By:
- Publication type:
- Article
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and Dodd.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 18, p. 2678, doi. 10.1002/sim.6337
- By:
- Publication type:
- Article
Treatment-shortening regimens for tuberculosis: updates and future priorities.
- Published in:
- Breathe, 2023, v. 19, n. 3, p. 1, doi. 10.1183/20734735.0028-2023
- By:
- Publication type:
- Article
Setting Tuberculosis Regimen Development on a Firm Foundation.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
An Analysis With Serious Flaws.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article